Nearly 95% of viral Korean skincare videos on TikTok make misleading claims, according to a study reported by Medical Dialogues. The finding lands at a moment when Korean beauty products — formulated around actives such as niacinamide, centella asiatica, snail mucin and various beta-hydroxy and polyhydroxy acids — command a growing share of the over-the-counter skincare market, with TikTok functioning as a primary discovery channel for younger consumers.

The near-universal rate of misleading content is the striking element here. This is not a finding of occasional exaggeration among mostly reliable sources. It indicates that virality on the platform, at least within the Korean skincare niche the study examined, correlates with content that fails basic standards of claim accuracy.

For dermatologists, the study adds quantitative weight to a complaint already common in clinic: patients arrive with product expectations shaped by short-form video, then present with irritation, barrier disruption or untreated inflammatory disease that an influencer's routine obscured. A patient with papulopustular rosacea cycling through a ten-step K-beauty routine sourced from TikTok is a familiar scenario. So is the patient with moderate acne who delayed effective topical retinoid therapy in favor of viral "skin-calming" products.

The report does not, based on the available summary, break down the specific categories of misleading claims — whether they concern efficacy, ingredient safety, exaggerated therapeutic benefit, or comparisons to prescription therapies. That breakdown matters clinically. Claims that a cosmeceutical outperforms an approved topical corticosteroid or a retinoid raise a different regulatory and counseling problem than aesthetic exaggeration about glow or texture. Clinicians should watch for the full publication, which should specify the coding methodology used to classify claims as misleading and the sample size behind the 95% figure.

The Korean skincare category deserves a measured response rather than a dismissive one. The category includes well-formulated products with meaningful concentrations of evidence-backed actives, and several K-beauty sunscreens have performed well in independent SPF testing. The study's target is not the formulation science. It is the claims apparatus attached to viral distribution — a distribution system that rewards engagement rather than accuracy, and that operates largely outside the advertising oversight applied to manufacturer communications.

That distinction should inform how dermatologists counsel patients. Dismissing a patient's K-beauty routine outright risks losing the encounter. A more productive approach reviews the actual ingredient list, identifies actives and their concentrations where stated, flags known irritants or allergens for that patient's skin type, and separates what the product can plausibly do from what the video promised.

The finding also carries implications for professional societies and patient-education strategy. If misleading claims saturate the most-viewed content in a major skincare category, accurate dermatologic information is not merely underrepresented on TikTok — it is being outcompeted by design of the platform's recommendation mechanics. Societies and individual clinicians producing short-form video content are working against an algorithmic headwind, not a neutral information environment.

Expect this study to join the growing literature base informing digital-health guidance in dermatology, and watch for follow-up analyses that examine whether the misleading-claim rate in Korean skincare content differs from that in other skincare categories, such as acne or anti-aging, on the same platform.